Digital Therapeutics and Wellness Market Share, Size, Trend & Global Industry Analysis By 2032

Global Digital Therapeutics and Wellness Market Overview

Global Digital Therapeutics and Wellness Market was valued at USD 7.94 Billion in 2024 and is expected to reach USD 73.49 Billion by 2032, at a CAGR of 32.07%.

Digital therapeutics (DTx) is a digital health category referred by the Digital Therapeutics Alliance as products that provide evidence-based therapeutic involvement to patients that are turned by high-quality software programs to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are distinct from digital medicines or “smart pills,” which combine a prescription medication with an ingestible sensor that is designed to communicate with a software application to track compliance. Development in and the increasingly dominant role of mobile technology and artificial intelligence (AI) in our everyday lives have expanded the role of digital therapeutics and wellness in healthcare. Even though historically, interest in emerging digital therapeutics was mainly confined to academia and technology companies, the potential to use digital therapeutics in conjunction with medicines to enhance health outcomes has sparked the interest of big pharma, who have started to venture into the digital therapeutics space through investments and strategic partnerships with tech companies. The rise in the tech-savvy population and the growing inclination towards software applications for yoga, exercise, and diet solutions is expected to propel the growth of the digital therapeutics and wellness market over the forecast period.

Market Dynamics And Key Factors For Digital Therapeutics and Wellness Market

Drivers:

The pandemic has triggered an increase in virtual care practice in the remote and home healthcare segments across the world. As Digital Therapeutics interventions are commonly delivered through smartphones, tablets, or IoT devices, new cloud-based platforms provide online diagnosis and consultation. Many blue ocean companies are start-ups are investing in AI-based digital platforms to create a streamlined solution and consulting systems can be provided to a larger crowd to treat chronic illness and mental health therapies. Such health condition needs a serious and quick response from the health care provider which is certainly the main key driving factor for Digital Therapeutic and wellness market growth. With the service base solution, many advanced tech companies investing in the development of digital health devices which can provide vital assistance as well as diagnosis promptly.

New-gen smart heart monitoring devices, diabetic control devices, blood glucose sensors, and blood pressure monitors have evolved by integration of machine learning, big data, and Artificial Intelligence to provide high accuracy data and diagnosis which is certainly driving the digital therapeutics and wellness market in the projected timeframe. The rise in adoption of smartphones and tablets, coupled with healthcare apps, growth in need to control healthcare cost, significant benefits to the entire healthcare continuum, and increase in incidences of chronic diseases increased the adoption of solutions offered by digital therapeutics. Digital therapeutics has made the management of diabetes, hypertension, blood pressure, and smoking convenient due to software-based applications and live tutorials on a smartphone thus, strengthening the expansion of the digital therapeutics and wellness market throughout the projected timeframe.

Restraints:

Digital Therapeutics and wellness solutions are based on connectivity, cloud-based infrastructure, and valuable data transfer. Due to the sensitive data exposed on web-based platforms, there is a high risk of data security which can be crucial in case of data heist or cyber-attack on such servers. Cybersecurity and data rights are the main requirements for the mass adoption of digital therapeutics solutions. Moreover, Digital Therapeutics devices such as connected sensors in medicines and heart monitoring devices, as a digital treatment that transfer information over the internet have a certain risk of unauthorized access and manipulation of these devices and underlying data could compromise both trust in the product and patient care thus, hampering the development of the digital therapeutics and wellness market in the forecasted period.

Opportunities:

The Technological shift in digital tools and devices integrated into daily lifestyle provides a certain opportunity in creating digital health integrated platforms and solutions as increasing dominance of mobile technology and artificial intelligence and IoT devises in everyday activity. These market trends are a suitable opportunity for Digital Therapeutics and wellness companies to integrate new prospects such as electronic health records, virtual visits, mobile health, wearable technology, artificial intelligence, and machine learning in digital therapeutics. Progress of therapeutic applications in various range of neuroscience indications like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), Schizophrenia, Depression, and bipolar disorder provides scope for commercial research and development. Moreover, the growing usage of smartphones and the ready adoption of digital treatment services can create a profitable opportunity for the market players.

Market Segmentation

Segmentation Analysis of Digital Therapeutics and Wellness Market:

Depending on device type, the blood pressure monitor segment is forecasted to have the highest share of the digital therapeutics and wellness market. Blood pressure should be monitored because long-term high blood pressure can damage arteries and the heart. It is feasible to assess if drugs are needed or effective by measuring blood pressure. Home usage digital blood pressure monitors are not only designed to check blood pressure but also measures pulse rate, and can detect an irregular heartbeat. The growing prevalence of diabetes and other disorders that directly affects blood pressure has stimulated the adoption of digital blood pressure monitors thus, consolidating the development of the segment.

Depending on the technology, cellular technology is anticipated to lead the growth of the digital therapeutics and wellness market in the analyzed period. Telemedicine/Telehealth and mHealth are the two main categories developed due to the advancement in cellular technology. With the growing usage of mobile devices (e.g., smartphones, tablets) in everyday lives, people have the ability to communicate and share information faster than ever before. As a result, innovative apps focused on enhancing health and healthcare delivery for individuals with limited access have been developed. Hospice care, which is commonly provided at home, may particularly benefit from the usage of this technology platform. Multiple potential benefits are offered by mobile health (mHealth) applications and these can be incorporated into existing home hospice care. Mobile health is freeing healthcare devices of wires and cords and enabling physicians and patients alike to check on healthcare processes on the go thus, helping the growth of this segment.

Depending on end-use, the obesity weight loss segment is expected to dominate the digital therapeutics and wellness market during the projected timeframe. The usage of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index (BMI), this reduces the likelihood of comorbidities, according to research presented at the American Association of Clinical Endocrinologists' 30th Annual Scientific and Clinical Congress. Clinicians can use digital therapeutic platforms to provide lifestyle-modification therapies remotely. Even in resource-constrained settings, these treatments have the potential to affect weight reduction in persons with obesity and metabolic syndrome by providing evidence-based care. Digital therapeutics can help patients remotely manage their weight and calorie intake thus, driving the growth of this segment.

Regional Analysis of Digital Therapeutics and Wellness Market:

The North American region is expected to have the lion's share of the digital therapeutics and wellness market throughout the forecast period. According to Bigfoot Biomedical Inc, approximately 2 million individuals in America utilize continuous glucose monitoring devices (CGM) to monitor their glucose levels. These devices check the blood glucose at specific intervals and then depending on the level of insulin automatically pump insulin or alert the wearer to take an insulin shot. The growing popularity of CGM devices along with other digital equipment among individuals is strengthening the expansion of the digital therapeutics and wellness market in this region.

The European region is anticipated to have the second-highest share of the digital therapeutics and wellness market. According to Statista, the number of people utilizing digital therapeutics in Europe was 6.4 million in the year 2020. This number is expected to reach 160.3 million by 2027. The growing prevalence of hypertension and other disorders that leads to hypertension has stimulated the usage of digital blood pressure monitors. According to Europa, 22% of the people aged 15 years and above reported high blood pressure in 2019. The convenience offered by digital blood pressure monitors has stimulated the rapid adoption of these devices thus, supporting the growth of the digital therapeutics and wellness market in this region over the projected period.

The digital therapeutics and wellness market in the Asia-Pacific region is expected to register the highest CAGR growth in the forecast period. The growing adoption of smart technologies and the inclination towards smart devices to monitor glucose, and blood pressure has boosted the growth of the market in this region. Digital wellness applications offered by market players are widely utilized by individuals in this region to quit smoking and alcohol consumption. People suffering from depression are also using this app to overcome it thus, the demand for digital therapeutics and wellness applications is expected to exponentially rise in this region throughout the forecast period.

Key Players Covered in Digital Therapeutics and Wellness Market are:

• Proteus Digital Health
• Omada Health
• Welldoc
• A&D
• Omron
• Qardio
• Virgin Pulse
• Livongo Health
• Noom
• Ginger
• Propeller Health
• 2morrow
• Canary Health
• Mango Health
• My mHealth
• Glytec
• Proteus
• Vida Health
• Blue Mesa Health
• Click Therapeutics
• CureApp
• Digital Therapeutics Inc
• Akili Interactive Labs
• AppliedVR
• Brain Power
• 7Cups
• Calm
• Fitbit
• Onlife Health
• Provant Health
• WellDoc
• Twine Health
• Medtronic
• Big Health and other active players.

COVID-19 Impact on Digital Therapeutics and Wellness Market

COVID-19 pandemic can be considered as the main factor that has stimulated the rapid expansion of the digital therapeutics and wellness market. Digitalization of healthcare was already perceived to be inevitable, representing the future of healthcare delivery across the world. Many digital health solutions have been launched to help in general wellness and health maintenance, as well as illness screening and diagnosis, treatment, and prognosis estimation. The term 'Digital Therapeutics (DTx)' refers to evidence-based digital treatments that are designed to offer therapy for certain disease domains and function primarily by inducing behavioral changes out of all of these solutions. In North America, there has been a climb in care about progressed prosperity, abhorrence of real visits to offices to reduce the credibility of infection, and development in mental wellbeing issues raised interest for modernized therapeutics during the Covid-19 pandemic. Digital therapeutics new organizations and driving players have been tending to conditions, for instance, Type 2 diabetes, impulse, compound lop-sidedness, and musculoskeletal injuries through video meetings, conveying instructive accounts and destinations on their locales, and scattering clinical benefits programs through applications. People have started mentioning solutions and clinical contraptions over web channels after receiving drugs and therapies remotely. To summarize, the COVID-19 pandemic has boosted the adoption rate of digital therapeutics and wellness solutions.

Recent Industry Developments In Digital Therapeutics and Wellness Market

• In August 2024, Pfizer Inc. launched PfizerForAll, a user-friendly digital platform to enhance healthcare access and wellness management for Americans. This comprehensive tool supports those affected by common illnesses such as migraine, COVID-19, and flu, while also assisting individuals seeking adult vaccinations. By consolidating essential resources and services into one accessible destination, PfizerForAll streamlines the process of obtaining care, filling prescriptions, and discovering savings on Pfizer medications, ultimately helping families take important health actions more efficiently.
• In November 2024, NASHVILLE, Tenn. and AACHEN, Germany, – BehaVR and Fern Health have announced a merger to create RealizedCare, a digital care management solution for chronic pain. This innovative platform combines digital therapeutics with traditional services, addressing the rising demand for scalable, evidence-based mental and behavioral health solutions. With support from Grünenthal as a strategic investor, RealizedCare aims to transform chronic pain management for the 52 million adults affected in the U.S., delivering personalized, outcome-focused care.